Literature DB >> 7513689

Evidence for a second alpha 2-macroglobulin receptor.

U K Misra1, C T Chu, G Gawdi, S V Pizzo.   

Abstract

alpha 2-Macroglobulin (alpha 2M)-methylamine binds to purified low density lipoprotein receptor-related protein (LRP), and it is assumed that LRP functions as the alpha 2M receptor in vivo. Binding of alpha 2M-methylamine to macrophage receptors elevates intracellular calcium ([Ca2+]i), inositol phosphates, and cyclic AMP. We have employed human alpha 2M-methylamine and recombinant receptor binding fragment (RBF) to study transduction mechanisms. Macrophages exposed to either ligand demonstrated a rapid rise in [Ca2+]i. Since the 39-kDa LRP/alpha 2M receptor-associated protein (RAP) blocks alpha 2M binding to LRP, we explored the effects of RAP upon signaling. Pretreatment of macrophages with RAP did not block the increase in [Ca2+]i elicited by alpha 2M-methylamine or RBF, suggesting a distinct binding site. RBF also elicited a transient 1.5-2.0-fold increase in inositol 1,4,5-triphosphate. In permeabilized macrophages, GTP gamma S and Gp-p(NH)p potentiated and sustained this inositol 1,4,5-triphosphate increase. Preincubation of permeabilized macrophages with GDP beta S abrogated the effects of GTP gamma S. Our results suggest that the signaling alpha 2M receptor is coupled to a pertussis toxin-insensitive G protein and possibly to a cholera toxin-sensitive G protein. We conclude that macrophages contain a second alpha 2M receptor that is G protein-coupled.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513689

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14.

Authors:  G J Riely; J Rachmilewitz; P H Koo; M L Tykocinski
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Gastrointestinal absorption and biological activities of serine and cysteine proteases of animal and plant origin: review on absorption of serine and cysteine proteases.

Authors:  Gerhard Lorkowski
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-02-28

3.  Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses.

Authors:  Uma Kant Misra; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

Review 4.  Low-density lipoprotein receptor family: endocytosis and signal transduction.

Authors:  Y Li; J Cam; G Bu
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

5.  Effect of alpha2-macroglobulin on retinal glial cell proliferation.

Authors:  Ivan Milenkovic; Gerd Birkenmeier; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

6.  Self antigen prognostic for human immunodeficiency virus disease progression.

Authors:  C L Bristow; H Patel; R R Arnold
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

7.  LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking.

Authors:  Sripriya Ranganathan; Nathaniel C Noyes; Mary Migliorini; Jeffrey A Winkles; Frances D Battey; Bradley T Hyman; Elizabeth Smith; Manuel Yepes; Irina Mikhailenko; Dudley K Strickland
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

8.  Loss of cell surface TFII-I promotes apoptosis in prostate cancer cells stimulated with activated α₂ -macroglobulin.

Authors:  U K Misra; Y M Mowery; G Gawdi; S V Pizzo
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

9.  Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein.

Authors:  L Goretzki; B M Mueller
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies.

Authors:  Ana M Sanchez; Thomas N Denny; Maurice O'Gorman
Journal:  J Immunol Methods       Date:  2014-06-06       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.